For the two million Americans diagnosed with cancer each year, the emotional toll of absorbing the news is often exacerbated by uncertainty about the variety of treatments, and confusion trying to navigate a fragmented healthcare system. Accompanying patients on that journey and smoothing the way for them is where Thyme Care enters the picture, a company that supports and supplements the care provided by oncology practices at no cost to patients. “We do the types of things that everybody in the oncology space knows should be done, but it’s often hard to operationalize them at scale,” says Dr. Brad Diephuis, the company’s chief business officer and a cancer survivor himself. Those things include tracking patient reported outcomes and providing proactive symptom monitoring throughout cancer treatment in order to catch problems early and prevent unnecessary interventions and hospitalizations. Data presented at the American Society of Clinical Oncology conference in 2022 indicates Thyme Care is delivering on its value proposition for insurance plans and other payers: reducing costs and increasing patient satisfaction. Join host Michael Carrese in learning why Diephuis thinks its shared savings model is succeeding, how its “care pod” model works, and what the company’s plans are for growth.Mentioned in this episode: https://www.thymecare.com/